A股大医药概念早盘震荡走高，CRO、重组蛋白、创新药等概念涨幅居前；美迪西涨超16%，毕得医药涨超7%，昭衍新药、阳光诺和、诺思格等个股跟涨。国家发改委表示，“十四五”以来，402种药品新增进入国家医保药品目录。

Group 1 - The A-share pharmaceutical sector experienced a strong upward trend in early trading, with significant gains in concepts such as CRO, recombinant proteins, and innovative drugs [1] - Companies like Medisi saw an increase of over 16%, while Bid Pharma rose more than 7%, with other stocks like Zhaoyan New Drug, Sunshine Nuohuo, and Nossger also following suit [1] - The National Development and Reform Commission announced that since the 14th Five-Year Plan, 402 new drugs have been added to the national medical insurance drug list [1]